跳至主要内容
临床试验/JPRN-UMIN000003963
JPRN-UMIN000003963已完成未知

Study on the effect of a combination therapy of H2 receptor antagonist and 5-HT3 receptor antagonist for the treatment of dyspepsia with mild irritable bowel syndrome - Effect of a combination therapy of H2RA and 5-HT3RA for the treatment of dyspepsia with IBS

Hyogo College of Medicine0 个研究点目标入组 100 人开始时间: 2010年7月28日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1.Patient who has a history of hypersensitivity 2.Patient who has organic illness such as gastroduodenal ulcer, gastric cancer, intestinal cancer or imflammatory bowel disease 3.Patient with chronic constipation or constipated IBS 4.Patient who is currently receiving H2RA, PPI or drugs for IBS 5.Patient who has renal disorder 6.Patient who has cardiovascular diseases 7.Patient who has hepatic disorder 8.Patient who is pregnant nursing mom 9.Patient wit whome the physicina-in-charge considered inappropriate as a subject of the study

研究者

相似试验